国内荷斯坦种公牛HH4遗传缺陷基因筛查

HH4是新近在荷斯坦牛中发现的一种遗传缺陷,其分子机理为牛1号染色体上的GART基因编码区内的1个A/C错义突变。该遗传缺陷呈隐性遗传、突变等位基因纯合时,导致胚胎早期死亡。本研究针对HH4建立了基于PCR-RFLP技术的分子检测方法。结果表明:通过对466头国内荷斯坦种公牛进行基因筛查,发现6头携带者,均可以追溯到共同的祖先公牛Besne Buck。建议我国今后进口荷斯坦种牛时,对个体进行系谱分析和遗传缺陷基因分子检测,避免引入有害基因;同时,对国内现有荷斯坦公牛群体进行HH4筛查,明确标注每头公牛的携带状态,以便在生产实践中合理选种选配。     

荷斯坦牛新遗传缺陷单倍型HH7分子筛查

HH7(Holstein Haplotype 7)是在荷斯坦牛群中新发现的一种隐性遗传缺陷单倍型,由27号染色体上CENPU基因4个碱基缺失突变引起,隐性基因纯合时能引起胚胎早期流产,严重影响着奶牛养殖者的经济效益。本研究利用竞争性等位基因特异性PCR(KASP法)对随机抽取的166头荷斯坦公牛样本进行了检测分析,结果表明,在所检测的荷斯坦公牛中未发现HH7携带者个体。提示新缺陷单倍型HH7在北京地区的荷斯坦牛群中比例可能很低,但在全国牛群中的分布情况尚不清楚,建议继续开展相关研究,并在种牛遗传物质引进时重点关注,避免将新缺陷基因引入进来,造成有害基因的广泛传播。     

中国荷斯坦牛HH4遗传缺陷单倍型分子筛查

HH4(Holstein Haplotype 4)是在荷斯坦牛群中发现的一种隐性遗传缺陷单倍型,由1号染色体上GART基因g.1277227AC单碱基错义突变引起,隐性基因纯合时引起胚胎早期流产,严重威胁着奶牛养殖者的经济效益。本研究利用飞行时间质谱技术对北京地区332头荷斯坦公牛样品和1 151头母牛样品进行了检测分析,结果表明,在所检测的荷斯坦牛群体中,未发现HH4携带者个体,即均为正常个体。提示HH4单倍型对我国荷斯坦牛群影响较小,在奶牛场的选种选配中可以不予考虑,但在遗传物质引进的时候应重点关注,避免引入有害基因。     

中国荷斯坦公牛CN和DUMPS遗传缺陷检测及系谱分析

旨在研究中国荷斯坦牛中瓜氨酸血症(Citrullinemia,CN)和尿苷酸核酶缺乏症(Deficiency of uridinemonophosphate synthase,DUMPS)2种遗传缺陷的携带者比率及系谱来源,并构建更简便的检测方法。本研究通过PCR-RFLP方法对参加我国联合青年公牛后裔测定和良种补贴项目的591头荷斯坦公牛进行了大规模CN和DUMPS的遗传缺陷检测,并构建了奶牛CN隐性有害基因的AS-PCR检测技术。结果,共发现2头CN和1头DUMPS隐性有害基因携带者公牛,携带者比例分别为0.34%和0.17%。经过系谱追溯,2头CN携带者公牛均为澳大利亚公牛Linmack Kriss King-CN后代,DUMPS携带者公牛为美国公牛Skokie sensation Ned后代。基于此,我国有必要尽快建立荷斯坦牛隐性遗传缺陷监控体系并进行系谱标注,通过青年公牛预选和选种选配,避免携带者公牛进入后裔测定和良种补贴项目,以逐步降低我国奶牛群体中隐性有害等位基因频率。     

天津地区荷斯坦公牛CVM、DUMPS和CN遗传缺陷检测

本文旨在研究天津地区中国荷斯坦公牛脊椎畸形综合征（Complex vertebral malformation,CVM）、尿苷酸合酶缺乏症（Deftciencv of uridine monophospham synchase,DUMPS）和瓜氨酸血症（Citrullinemia,CN）3种遗传缺陷的携带者比率及系谱来源。通过PIRA—PCR和PCR—RFLP方法分别对天津奶牛发展中心参加全国青年公牛联合后裔测定和国家良种补贴项目的110头荷斯坦公牛进行了CVM、DUMPS和CN三种遗传缺陷检测。共发现6头CVM隐性有害基因携带公牛,携带者比例为5．45％,隐性有害等位基因频率为2．72％。经过系谱分析,其中4头CVM携带者均为美国公牛Carlin—MIvanhoeBell的后代,另外2头因系谱不完整而无法查询。未检测到DuMPs和CN隐性有害基因携带者。基于此,我国有必要尽快建立荷斯坦牛隐性遗传缺陷监控体系并进行系谱标注,避免携带公牛进入后裔测定和良种补贴项目,以逐步降低我国奶牛群体中遗传缺陷隐性等位基因频率。     

奶牛隐陛遗传缺陷脊椎畸形综合征的SSCP分析

丹麦科学家1999年首先发现了荷斯坦牛中存在的、造成大量流产和畸形犊牛的脊椎畸形综合征（CVM）遗传缺陷。全世界奶牛业已经验证并认同丹麦科学家的研究结果，世界各国纷纷采取措施对付这种有史以来因遗传原因给荷斯坦牛造成巨大损失的疾病。我国奶牛群中也同样存在着隐性遗传缺陷CVM问题，可能已经给奶牛场造成巨大的损失。本文介绍了奶牛CVM的概况和CVM隐性遗传缺陷基因的分子检测方法，分析了其遗传机理和传递规律．以及国外对CVM的发现、检测和处理办法，介绍了控制CVM的关键点。北京奶牛中心在国内率先对本单位的150头荷斯坦种公牛和140头荷斯坦母牛进行DNA测定，对种公牛和母牛的DNA样品进行了SSCP分析，结果表明，在所检测的150头种公牛中，有16头是CVM携带者，携带率为10．7％；140头母牛中，17头是携带者，携带率为12％。通过基因检测技术对种公牛进行选择．向养牛户提供CVM非携带者的公牛精液，避免CVM隐性遗传缺陷基因造成的经济损失．从而提高奶牛场的经济效益。     

奶牛隐性遗传缺陷脊椎畸形综合征的SSCP分析

丹麦科学家1999年首先发现了荷斯坦牛中存在的、造成大量流产和畸形犊牛的脊椎畸形综合征(CVM)遗传缺陷.全世界奶牛业已经验证并认同丹麦科学家的研究结果,世界各国纷纷采取措施对付这种有史以来因遗传原因给荷斯坦牛造成巨大损失的疾病.我国奶牛群中也同样存在着隐性遗传缺陷CVM问题,可能已经给奶牛场造成巨大的损失.本文介绍了奶牛CVM的概况和CVM隐性遗传缺陷基因的分子检测方法,分析了其遗传机理和传递规律.以及国外对CVM的发现、检测和处理办法.介绍了控制CVM的关键点.北京奶牛中心在国内率先对本单位的150头荷斯坦种公牛和140头荷斯坦母牛进行DNA测定,对种公牛和母牛的DNA样品进行了SSCP分析,结果表明,在所检测的150头种公牛中,有16头是CVM携带者,携带率为10.7%:140头母牛中,17头是携带者,携带率为12%.通过基因检测技术对种公牛进行选择.向养牛户提供CVM非携带者的公牛精液,避免CVM隐性遗传缺陷基因造成的经济损失,从而提高奶牛场的经济效益.     

荷斯坦牛的尿苷—磷酸合成酶缺陷

尿苷-磷酸合成酶缺陷(DUMPS)是荷斯坦牛中发生的一种致死性遗传病,呈常染色体隐性遗传,其杂合子对健康无不良影响,而隐性基因的纯合子会导致胚胎在怀孕40天左右死亡。估计美国荷斯坦黑白花牛中DUMPS的携带者占1％—2％。鉴于美国牛的精液、胚胎和种牛有全球市场,所以在     

中国荷斯坦牛白细胞粘附缺陷病遗传分析

荷斯坦牛白细胞粘附缺陷病（BLAD）是一种遗传性免疫缺陷病，患病牛出生后，生长发育差，绝大多数在1年内死亡，且不具繁殖和哺育能力。该病的遗传基础为CD18基因编码区383位的A／G点突变导致白细胞表面的β2整合素表达缺陷。目前欧美等奶牛业发达国家都已经建立了完善的BLAD分子检测方法和跟踪监控体系。中国长期从国外进口荷斯坦公牛精液、胚胎或活体，由此可能引进了BLAD基因。本研究采用PCR—RFLP方法对116头可疑中国荷斯坦牛进行了检测．确定了2头BLAD携带者公牛和8头携带者母牛．未发现隐性纯合个体．     

北京地区荷斯坦牛脊椎畸形综合征的调查研究

脊椎畸形综合征（Complex Vertebral Malformation,CVM）是由常染色体上SLC35A3基因单碱基突变（G→T）引起的隐性遗传疾病,该基因隐性纯合（CV/CV）时奶牛致死,但CVM携带者表现正常,所以CVM携带者公牛可以通过人工授精技术传播CVM缺陷基因。本研究利用PCR-SSCP方法对北京地区242头公牛样品和403头母牛样品进行了检测分析,研究结果表明,在所检测的样本中,荷斯坦种公牛和母牛CVM携带率分别为8.82%和5.71%,CVM基因频率分别为4.41%和2.85%。通过系谱追踪发现,CVM遗传缺陷的共同祖先是美国名牛＂Penstate Ivanhoe Star＂（USA.1441440,CV）。通过剔除CVM携带者公牛可以有效地控制CVM遗传缺陷的传播,但是,我国许多CVM携带者公牛冻精依然在商业化使用,所以有效地监控CVM携带者在奶牛群中的状况对CVM防控计划是有益的。     

Genetic Description of Factor XI Deficiency in Holstein Semen in Western Japan

Factor XI deficiency was detected in Holstein cows and mummified foetuses in Japan; however, no report is available about the occurrence of Factor XI deficiency in Holstein semen in Japan. Five hundred cows in twelve dairy farms in Hiroshima Prefecture, Japan were under the study. Genomic DNA was extracted from the cows using a commercial DNA kits and screened to Factor XI mutation. Based on the information of the carrier cows found in the cattle population, four Holstein bulls were analysed for Factor XI mutation. DNA was extracted from bull's semen using phenol chloroform method. Extracted genomic DNA of the bull's semen was typed for Factor XI using specific polymerase chain reaction (PCR) primers. The resultant PCR was sequenced using big dye terminator sequencing method. The pedigree of the bulls was investigated. Furthermore, the inheritance of Factor XI mutation to next generation was estimated. Out of the 500 cows, five were heterozygous to Factor XI. Moreover, out of the four bulls, one was found to carry the mutation of Factor XI; it was also a complex vertebral malformation (CVM) carrier. In DNA sequencing, the insertion mutation of 76 bp of poly-adenine that characterizes the Factor XI deficiency was detected in the carrier bull as well as the carrier cows. Pedigree analysis of the carrier bull revealed that his father and mother ID were 2247419A and 14189172A, respectively, that originated from USA Holstein. Out of six daughter cows born to the carrier bull, one cow (16.6%) inherited Factor XI mutation, while three of them (50.0%) inherited CVM mutation. Autosomal recessive genes that affect cow's reproduction have a particular concern to dairy industry. To our knowledge this is the first report of Factor XI mutation in Holstein semen in Japan.     

DNA extraction from bovine mummified fetuses and detection of factor XI gene deficiency in the mummies

Genomic DNA extracted from bovine mummified tissue is valuable material for detection of some genes that may contribute to fetal abnormalities. In this study bovine genomic DNA was extracted from the hardened tissue samples of ten bovine mummified fetuses. The amount of genomic DNA extracted from 2 g of the mummified tissues by the phenol/chloroform-ethanol method was low (less than 4 microg/ml) for all samples. The extracted DNA was then amplified by the GenomiPhi DNA amplification system. After amplification, the amount of DNA was increased to more than 100 microg/ml for all samples. This amplification system was shown to be a good tool for amplifying the genomic DNA of the mummified fetuses. The amplified genomic DNA was used for testing the mummies for Factor XI gene deficiency, an autosomal recessive deficiency involved in the early stages of the intrinsic blood coagulation pathway. Exon 12 of the Factor XI gene of the mummies was amplified by PCR. Two of the ten mummified fetuses were heterozygous for the Factor XI gene as indicated by the presence of two amplified DNA fragments of 320 bp and 244 bp. Factor XI deficiency has already been described in Holstein cattle. However, no report is available for bovine fetus. In this study, DNA was extracted and amplified from the bovine mummified fetuses, and the samples were successfully tested for Factor XI gene deficiency in the mummies.     

Factor XI mutation in a Holstein cow with repeat breeding in Japan

Factor XI deficiency is an autosomal recessive coagulopathy in Holstein cattle. Affected cows have a tendency to show repeat breeding. Forty repeat breeding Holstein Friesian cows were selected and tested for the Factor XI mutation. Genomic DNA was isolated from the blood of the cows (n=40). Exon 12 of the Factor XI gene of the cows was amplified by PCR. One repeat breeding cow was heterozygous to the Factor XI mutation as indicated by the presence of two DNA fragments of 320 bp and 244 bp. The insertion of the 76 bp in the heterozygous cow was confirmed by DNA sequencing. The heterozygous cow was in her fourth lactation. She gave birth to male twins at the last calving. She was inseminated artificially four times after the last calving. Factor XI deficiency in cattle has been reported in different countries. However, no case was reported in Japan. This might be the first to report Factor XI mutation in Holstein cattle in Japan.     

The relationship between factor XI coagulant and factor XI antigenic activity in cattle.

Factor XI protein, isolated from normal bovine plasma, was used to raise antiserum in rabbits. The antisera was partially purified and used in a neutralization-inhibition assay to investigate the relationship between factor XI coagulant activity and antigenic material in the plasma of normal cattle and cattle homozygous and heterozygous for factor XI deficiency. Factor XI antigen was reduced in both the homozygous and heterozygous animals to levels comparable to the factor XI coagulant activity. The reduction of immunologically cross-reactive material to normal factor XI suggests that the factor XI coagulation defect is associated with the absence of a normal protein.     

Coagulation factor XI deficiency in Holstein cattle: expression and distribution of factor XI activity.

Factor XI (F XI) is a plasma protein that participates in the blood coagulation process. A study of the expression of F XI activity in Holstein cattle has confirmed that the inheritance of F XI deficiency is autosomal with severe deficiency in homozygotes (mean F XI level 2%, SD 1%), and partial deficiency in heterozygotes (mean F XI level 38%, SD 10%; normal mean F XI level 94%, SD 21%). In a total of 1469 males evaluated for F XI levels, 47 or 3.1% were identified as heterozygous and only one as homozygous for the disorder. In part because of the lack of a discrete distinction in the expression of F XI between heterozygous and normal animals, not all of the animals tested could be uniquely classified on the basis of the plasma F XI values. A mean F XI value of 53% (SD 7%) was found in a group of animals that were categorized as low normal/high heterozygous. If this group of cattle had been classified on the basis of the criterion used to classify human beings then these animals would have been categorized as heterozygous since the mean F XI value for proven bovine heterozygotes is approximately 20% lower than the values found in the human counterpart. Like the human form of the disease, however, there appears to be a low frequency of hemorrhagic episodes associated with F XI deficiency in cattle.     

Failure of Routine Coagulation Screening Tests to Detect Heterozygous State of Bovine Factor XI Deficiency

In a survey of coagulation, biochemical and hematological parameters in cattle homozygous (deficient), heterozygous (carrier) and non-affected (normal) for Factor XI deficiency, only the Activated Partial Thromboplastin Time (APTT) results correlated with plasma Factor XI activity levels. The APTT results and the thrombokinetics for the deficient animals were markedly different from the results of either the carrier or normal animals. However, the APTT assay was shown not to be sufficiently sensitive to differentiate between the normal and carrier state for the coagulation disorder. Not only was there no statistical difference between the mean APTT results for the normal and carrier animals, but the thrombokinetics for fibrin clot formation for the two groups were also similar.     

Identification of factor XI deficiency in Holstein cattle in Turkey

Background

Factor XI (FXI) is a plasma protein that participates in the formation of blood clots. Factor XI deficiency is autosomal recessive hereditary disorder that may be associated with excess bleeding in Holstein cattle.

Methods

In this study, 225 Holstein cows reared in Turkey were screened in order to identify FXI genotypes. DNA extractions were obtained from the fresh blood of the cows. Amplicons of FXI exon 12 were obtained by Polymerase Chain Reaction (PCR), and analyzed by 2% agarose gel electrophoresis stained with ethidium bromide. Additionally, all cows were confirmed by DNA sequencing to determine whether or not there was a mutant allele.

Results

Carriers of the FXI deficiency have two DNA fragments of 320 bp and 244 bp in size. The results of our study demonstrated that only four out of the 225 Holstein cows tested in Turkey carried the FXI deficiency. The frequency of the mutant FXI allele and the prevalence of heterozygous cows were found as 0.9% and 1.8%, respectively.

Conclusion

The DNA-based test determines all genotypes, regardless of phenotype or FXI activity. The mutation responsible for the FXI deficiency had not been detected in Holstein cattle in Turkey before prior to this study. The frequency of the mutant FXI allele needs to be confirmed by carrying out further analyses on cattle in Turkey and the selection programs should be developed to eliminate this genetic disorder.     

Congenital factor XI deficiency in a domestic shorthair cat

A 6-month-old, female, domestic shorthair cat was examined after onychectomy and ovariohysterectomy because of bleeding from the paws. Prolonged activated partial thromboplastin time was discovered, Coagulation factor analyses revealed deficiency of factor XI coagulant activity. Plasma mixing studies indicated factor deficiency or dysfunction rather than factor inhibition. Feline factor XI deficiency in one adult cat has been previously reported but was attributed to factor XI inhibitors. The signalment, lack of primary disease, and the finding of persistent factor XI deficiency in the absence of coagulation inhibitors were considered compatible with congenital factor XI deficiency in the cat of this report.     

Pedigree analysis of factor XI deficiency in Japanese black cattle

Using a DNA-based diagnostic test for factor XI deficiency in Japanese black cattle, we surveyed 123 cattle (42 sires and 81 dams) in Gifu and Hyogo prefectures, and calculated gene frequencies. In sires, we drew up the pedigree network of the cattle with the factor XI deficiency. Results showed that the mutated allele of factor XI deficiency was retroactive in at least 6 or more generations of sires. Frequencies of the mutant gene were higher at 26.4% in total, and at 33.3% in sires. All 7 cattle with the homozygote of mutated allele were clinically normal, and showed no bleeding episodes. The mutated allele of factor XI deficiency might be widespread among Japanese black cattle.     

Factor XII and partial prekallikrein deficiencies in a dog with recurrent gastrointestinal hemorrhage

Factor XII deficiency and impaired prekallikrein activity were diagnosed in a 1-year-old Chinese Shar Pei. The dog experienced repeated episodes of intestinal hemorrhage and diarrhea. Laboratory findings were compatible with blood loss (iron deficiency anemia and hypoproteinemia). Necropsy findings suggested mild infiltrative bowel disease that could have been responsible for the dog's diarrhea, but no explanation for the severe recurrent gastrointestinal hemorrhage could be found. Factor XII deficiency is uncommon in the dog and is not associated with hemorrhagic tendencies. The factor XII deficiency in this case may have contributed to the gastrointestinal hemorrhage.